Literature DB >> 3484664

Staging and therapy of orbital lymphomas.

C L Bennett, A Putterman, J D Bitran, W Recant, C M Shapiro, J Karesh, U Kalokhe.   

Abstract

Ten patients with non-Hodgkin's lymphoma primarily affecting the orbital region were evaluated at Michael Reese Hospital and Medical Center, Chicago, between 1976 and 1983. Diagnoses were based on the histopathologic classification systems of the Working Formulation of the Non-Hodgkin's Lymphomas and Rappoport. Sequential staging procedures performed at the time of diagnosis included liver-spleen scans, Technecium-99 bone scans, gallium 67 scans, computerized axial tomograms of the orbit and abdomen, bone marrow examination and cerebral spinal fluid analyses. Adverse prognostic factors included the following: orbital bone erosions, Stage IV disease, and large cell or mixed cell, diffuse histologic features. The type of histopathologic findings combined with the results of sequential staging procedures is useful in identifying those patients who would benefit most from systemic chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484664     DOI: 10.1002/1097-0142(19860315)57:6<1204::aid-cncr2820570624>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases.

Authors:  Sarah E Coupland; Martin Hellmich; Claudia Auw-Haedrich; William R Lee; Harald Stein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

2.  Clinical course and pathologic features of conjunctival non-Hodgkin's lymphoma. A report of six cases.

Authors:  H A Khalil; R J de Keizer; P M Kluin; H C Kluin-Nelemans; D de Wolff-Rouendaal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type of the ocular adnexa: retrospective single institution review of 95 patients.

Authors:  Su-Ho Lim; Minkyu Kang; Junhyuk Son
Journal:  Indian J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.